Bayesian Classifier and Molecular Marker Platforms for Immune Monitoring

Rahul M. Jindal, Kristin A. Stevens, Jonathan A. Forsberg, Eric A. Elster*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Machine learning has been used in health care for over a decade. For example, models developed through this approach have been used in oncology to predict response to treatment based on tumor biomarker profiles. Machine learning is used in transplantation to elucidate biomarkers involved in the development of transplant glomerulopathy (TG), as a tool for deceased donor kidney allocation, and to increase the understanding of how beliefs within minority populations influence organ donation. In this chapter, these approaches are discussed in their current evolution and future directions with a focus on Bayesian belief networks (BBNs) and monitoring of immune status across transplantation.

Original languageEnglish
Title of host publicationStem Cell Biology and Regenerative Medicine
PublisherSpringer Nature
Pages125-132
Number of pages8
DOIs
StatePublished - 2015
Externally publishedYes

Publication series

NameStem Cell Biology and Regenerative Medicine
VolumePart F4880
ISSN (Print)2196-8985
ISSN (Electronic)2196-8993

Keywords

  • Bayesian
  • Biomarker
  • Classifier
  • Immune status
  • Machine learning
  • Molecular marker
  • Transplantation

Cite this